Painful heel spur Musculoskeletal Diseases Musculoskeletal pain
Conditions
Interventions
Radiotherapy to the plantar aponeurosis and the calcaneus:
1. Experimental arm: total dose of 0.6 Gy in single fractions of 0.1 Gy twice weekly, total duration three weeks
2. Standard arm: total dose
Sponsors
German Cooperative Group on Radiotherapy for Benign Diseases (GCGBD) (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Clinical proof of a painful heel spur with a duration of anamnesis of more than six months 2. Radiological proof of a heel spur using conventional radiographs 3. Facultatively: Magnetic Resonance Imaging (MRI/MRT), ultrasound, bone scan with proof of an inflammation of the plantar aponeurosis 4. Typical clinical symptoms: tenderness of the calcaneus 5. Typical functional deficits: limitation of the distance that can be walked without pain 6. Aged greater than or equal to 40 years 7. Karnofsky performance index greater than or equal to 70% 8. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Previous radiotherapy to the foot 2. Previous trauma to the foot 3. Additional rheumatic diseases, arterial obturation, severe venous insufficiency, lymphatic oedema of the leg involved 4. Pregnancy, time period of breastfeeding 5. Severe psychiatric disorder 6. Legal incapacitation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. 12-item Short Form health survey (SF-12): summed score, measured three months after the end of radiotherapy 2. Calcaneodynia summed score, measured three months after the end of radiotherapy 3. Visual Analogue Scale (VAS) score, measured three months after the end of radiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. SF-12: single scores, measured three months after the end of radiotherapy 2. Calcaneodynia single scores, measured three months after the end of radiotherapy 3. Painless time interval after therapy, measured three months after the end of radiotherapy | — |
Countries
Germany
Outcome results
None listed